Dantrium and neuroleptic malignant syndrome Patient Reports February 13, 2012

Dantrium Side Effects Report #5136871-3
Dantrium side effect was reported by a Physician from JAPAN on Oct 11, 2006. Female patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome, parkinson's disease  and was treated with Dantrium. After drug was administered, patient experienced the following side effects: acarodermatitis, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, neuroleptic malignant syndrome, red blood cell count decreased, urinary tract infection . Dantrium dosage: 20 MG TWICE DAILY, IV NOS. During the same period patient was treated with MADOPAR, AMAZOLON, DOPS, PERGOLIDE MESYLATE, SOLDEM, DEXTROSE, SOLDOL E. Patient recovered.

Dantrium Side Effects Report #4822777-3
Dantrium side effect was reported by a Physician from JAPAN on Oct 21, 2005. Female patient, 29 years of age, was treated with Dantrium. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Dantrium dosage: 160 MG DAILY, IV NOS. During the same period patient was treated with FAMOTIDINE, PANSOPORIN, VITAMEDIN CAPSULE, VISCORIN, FLAVITAN, PARLODEL, DIAZEPAM, LEXOTAN. Patient was hospitalized. Patient recovered.

Dantrium Side Effects Report #5360783-3
Dantrium side effect was reported by a Pharmacist from JAPAN on June 06, 2007. Male patient, 28 years of age, was diagnosed with analgesic effect and was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, body temperature increased, hyperhidrosis, muscle tightness, neuroleptic malignant syndrome, tonic convulsion, tremor. Dantrium dosage: 40 MG. During the same period patient was treated with VEGETAMIN A, GOODMIN, ROHYPNOL, TOLEDOMIN, LEXOTAN, PENTAZOCINE LACTATE, PENTAZOCINE LACTATE. Patient recovered.